Mangoceuticals, Inc. (MGRX)
NASDAQ: MGRX · IEX Real-Time Price · USD
0.415
-0.005 (-1.19%)
At close: Jul 26, 2024, 3:59 PM
0.430
+0.015 (3.61%)
After-hours: Jul 26, 2024, 7:41 PM EDT
Mangoceuticals Revenue
Mangoceuticals had revenue of $214.10K in the quarter ending March 31, 2024, with 112.56% growth. This brings the company's revenue in the last twelve months to $844.87K, up 670.43% year-over-year. In the year 2023, Mangoceuticals had annual revenue of $731.49K with 8,083.16% growth.
Revenue (ttm)
$844.87K
Revenue Growth
+670.43%
P/S Ratio
12.63
Revenue / Employee
$281,622
Employees
3
Market Cap
10.67M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 731.49K | 722.55K | 8,083.16% |
Dec 31, 2022 | 8.94K | - | - |
Dec 31, 2021 | - | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionMGRX News
- 2 days ago - MangoRx Initiates Efficacy Studies on its Patented Respiratory Illness Prevention Technology - GlobeNewsWire
- 8 days ago - Mangoceuticals CEO Jacob Cohen Featured on Benzinga All-Access - GlobeNewsWire
- 10 days ago - MangoRx Secures DEA Approval for Proprietary HIPAA-Compliant Operating System via Surescripts - GlobeNewsWire
- 14 days ago - MangoRx Appoints Dr. Douglas Christianson, N.D. as Director of the Medical Research and Product Innovation Department - GlobeNewsWire
- 15 days ago - MangoRx Announces Strategic Partnership for Expansion into Asia Pacific and Key Emerging Markets - GlobeNewsWire
- 7 weeks ago - MangoRx Receives Notice of Acceptance for Patent Application in Australia for Respiratory Illness and Preventive Care Technology - GlobeNewsWire
- 7 weeks ago - MangoRx Receives Patent Notice of Allowance in Japan for Revolutionary Preventive Care Technology Acquired from Intramont Technologies - GlobeNewsWire
- 2 months ago - Mangoceuticals, Inc. Announces Completion of First Batch of Mango ED Products for Marketing and Distribution in Mexico and Latin American Markets - GlobeNewsWire